Prognostic value of circulating tumor cells (CTC) in metastatic breast cancer (MBC): Correlation with immunohistochemically defined molecular subtypes and metastatic disease sites.

被引：1
|
作者：
Giordano, A.
Giuliano, M.
Hsu, L.
Handy, B. C.
Ueno, N. T.
Andreopoulou, E.
Alvarez, R. H.
Valero, V.
Hortobagyi, G. N.
Cristofanilli, M.
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.1000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1000
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Circulating Tumor Cells in metastatic Breast Cancer
    Krawczyk, Natalia
    Meier-Stiegen, Franziska
    Katzorke, Nora
    Janni, Wolfgang
    Mueller, Volkmar
    Rack, Brigitte
    Fasching, Peter
    Wallwiener, Diethelm
    Albrecht, Susanne
    Fehm, Tanja
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2014, 74 (11) : 986 - 988
  • [42] Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
    Naoki Hayashi
    Seigo Nakamura
    Yasuharu Tokuda
    Yuji Shimoda
    Hiroshi Yagata
    Atsushi Yoshida
    Hidekazu Ota
    Gabriel N. Hortobagyi
    Massimo Cristofanilli
    Naoto T. Ueno
    [J]. International Journal of Clinical Oncology, 2012, 17 : 96 - 104
  • [43] Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis
    Q. Lv
    L. Gong
    T. Zhang
    J. Ye
    L. Chai
    C. Ni
    Y. Mao
    [J]. Clinical and Translational Oncology, 2016, 18 : 322 - 330
  • [44] Prognostic and predictive value of circulating tumor cells in metastatic breast cancer patients treated with endocrine or chemotherapy
    Ellis, MJ
    Miller, MC
    Cristofanilli, M
    Budd, GT
    Stopeck, A
    Hayes, DF
    Doyle, GV
    Matera, J
    Terstappen, LWMM
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S7 - S7
  • [45] Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis
    Lv, Q.
    Gong, L.
    Zhang, T.
    Ye, J.
    Chai, L.
    Ni, C.
    Mao, Y.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (03): : 322 - 330
  • [46] Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
    Hayashi, Naoki
    Nakamura, Seigo
    Tokuda, Yasuharu
    Shimoda, Yuji
    Yagata, Hiroshi
    Yoshida, Atsushi
    Ota, Hidekazu
    Hortobagyi, Gabriel N.
    Cristofanilli, Massimo
    Ueno, Naoto T.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (02) : 96 - 104
  • [47] Prognostic values of circulating tumor cells (CTC) and cancer associated macrophage-like cells (CAML) enumerations in metastatic breast cancer: The role for innate immunity in the metastatic process
    Mu, Z.
    Wang, C.
    Ye, Z.
    Rossi, G.
    Austin, L.
    Yang, H.
    Cristofanilli, M.
    [J]. CANCER RESEARCH, 2017, 77
  • [48] Circulating tumor cells: a prognostic factor for newly diagnosed metastatic breast cancer
    Brossart, P
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (09) : 621 - 622
  • [49] A novel microfluidic system for the detection, enumeration and molecular analysis of circulating tumor cells (CTCs) in metastatic breast cancer (MBC)
    Paolillo, Carmela
    Mu, Zhaomei
    Toss, Angela
    Gogoi, Priyadarshini
    Sepehri, Saedeh
    Zhou, Yi
    Handique, Kalyan
    Zhong, Ye
    Yang, Hushan
    Capoluongo, Ettore
    Cristofanilli, Massimo
    Fortina, Paolo
    [J]. CANCER RESEARCH, 2015, 75
  • [50] Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    Cristofanilli, M
    Budd, GT
    Ellis, MJ
    Stopeck, A
    Matera, J
    Miller, MC
    Reuben, JM
    Doyle, GV
    Allard, WJ
    Terstappen, LWMM
    Hayes, DF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08): : 781 - 791
12345